FDA Mandates Blindness Warning for Ozempic and All GLP-1 Drugs Due to NAION Risk
Rapid Read

FDA Mandates Blindness Warning for Ozempic and All GLP-1 Drugs Due to NAION Risk

What's Happening? The U.S. Food and Drug Administration (FDA) has issued a new requirement for Ozempic, Wegovy, Mounjaro, Zepbound, and all other GLP-1 class drugs to carry a warning about Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION). NAION is a rare but serious optic nerve injury that c
AI Generated
This may include content generated using AI tools. Glance teams are making active and commercially reasonable efforts to moderate all AI generated content. Glance moderation processes are improving however our processes are carried out on a best-effort basis and may not be exhaustive in nature. Glance encourage our users to consume the content judiciously and rely on their own research for accuracy of facts. Glance maintains that all AI generated content here is for entertainment purposes only.